Kyle Moran plans sale of 3,564 WVE shares

Kyle Moran filed a notice of proposed sale for 3,564 ordinary shares of WVE, to be sold through Morgan Stanley Smith Barney LLC on NASDAQ around 02/09/2026, with an aggregate market value of $47,935.80.

Rhea-AI Filing Summary

Kyle Moran filed a notice of proposed sale for 3,564 ordinary shares of WVE, to be sold through Morgan Stanley Smith Barney LLC on NASDAQ around 02/09/2026, with an aggregate market value of $47,935.80. These shares were acquired via restricted stock unit vesting on 02/08/2026 as equity compensation.

During the prior three months, Kyle Moran sold 210,000 ordinary shares on 12/08/2025 for gross proceeds of $3,102,000.00 and 86,000 ordinary shares on 12/09/2025 for gross proceeds of $1,730,250.00. Ordinary shares outstanding were 187,693,059 at the time of the planned sale.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many WVE ordinary shares does Kyle Moran plan to sell in this Form 144?

Kyle Moran plans to sell 3,564 ordinary shares of WVE, according to the Form 144 notice. The shares have an aggregate market value of $47,935.80 and are expected to be sold on or about February 9, 2026 through Morgan Stanley Smith Barney LLC.

How did Kyle Moran acquire the WVE shares covered by this Form 144 filing?

The 3,564 WVE ordinary shares were acquired through restricted stock unit vesting on February 8, 2026. The filing states the securities were obtained from the issuer as equity compensation, rather than through a cash purchase on the open market.

What WVE share sales has Kyle Moran made in the last three months?

Over the last three months, Kyle Moran sold 210,000 ordinary shares on December 8, 2025 for $3,102,000.00 and 86,000 ordinary shares on December 9, 2025 for $1,730,250.00, as disclosed in the Form 144 filing.

On which exchange are the WVE ordinary shares in this Form 144 expected to be sold?

The Form 144 filing states that the ordinary shares are expected to be sold on NASDAQ. Morgan Stanley Smith Barney LLC Executive Financial Services is listed as the broker handling the planned sale of 3,564 WVE ordinary shares.

How many WVE ordinary shares were outstanding when Kyle Moran filed the planned sale?

The filing reports that 187,693,059 ordinary shares of WVE were outstanding in connection with the planned sale. This outstanding share figure provides context for the 3,564 shares covered by the current Form 144 notice.

What type of transaction is associated with the WVE shares in Kyle Moran’s Form 144?

The shares in this Form 144 are tied to a restricted stock unit vesting transaction dated February 8, 2026. The nature of payment is listed as equity compensation, indicating the shares were granted as compensation rather than bought for cash.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/09/2026 - 09:30 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001657765
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Wave Life Sciences Ltd.
SEC File Number	001-37627
Address of Issuer	7 Straits View #12-00 Marina One East Tower Singapore SINGAPORE 18936
Phone	65-6236 3388
Name of Person for Whose Account the Securities are To Be Sold	KYLE MORAN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
ordinary shares	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3564	47935.80	187693059	02/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ordinary shares	02/08/2026	Restricted Stock Unit Vesting	ISSUER			3564	02/08/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Kyle Moran 733 Concord Ave. Cambridge MA 02138	Ordinary Shares	12/08/2025	210000	3102000.00
Kyle Moran 733 Concord Ave. Cambridge MA 02138	Ordinary Shares	12/09/2025	86000	1730250.00

144: Remarks and Signature

Remarks	These sales were made pursuant to a provision in the reporting person's RSU agreement that requires automatic sales of shares to cover tax withholding obligations.
Date of Notice	02/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Kyle Moran
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)